✦ LIBER ✦

Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: Immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination

✍ Scribed by Heimo Lagler; Judith M. Wenisch; Selma Tobudic; Guido A. Gualdoni; Susanne Rödler; Susanne Rasoul-Rockenschaub; Peter Jaksch; Monika Redlberger-Fritz; Theresia Popow-Kraupp; Heinz Burgmann

Book ID: 116964077
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 302 KB
Volume: 29
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2011.07.050

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pandemic whole-virion, Vero-cell-derived

Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic situation

✍ Heimo Lagler; Selma Tobudic; Michael Ramharter; Katarzyna Elandt; Wolfgang R. Sp 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 706 KB

Safety and immunogenicity of inactivated

Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults

✍ Wendy A. Keitel; Cornelia L. Dekker; ChrisAnna Mink; James D. Campbell; Kathryn 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Assessment of the immunogenicity and saf

Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects

✍ Hiroyuki Fukase; Hidetoshi Furuie; Yuji Yasuda; Ryoya Komatsu; Kenji Matsushita; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 397 KB